文献速递重症综合管理与镇静镇痛

极端高龄危重症:澳大利亚和新西兰百岁老人ICU收治的结局与临床特征

Critical illness at extreme age: outcomes and clinical characteristics of centenarian ICU admissions in Australia and New Zealand.
PubMed 文献 · Crit Care · 2026-03-25
一句话结论百岁老人ICU收治高度选择,院内死亡率13.7%,死亡与急性病情严重度相关而非实际年龄,ANZROD判别力优于SOFA和APACHE III。

这项回顾性队列研究纳入2010至2024年澳大利亚和新西兰重症监护学会成人患者数据库中所有年龄≥100岁的首次ICU收治记录,共460例百岁老人,中位年龄100.9岁(IQR 100.3–102.0),女性占67.2%,外科收治为主(67.2%)。33.9%记录了治疗限制医嘱,10.3%使用有创机械通气。院内死亡率为13.7%,ICU死亡率为3.9%,死亡多发生在住院早期;医院存活者中54.1%出院回家,出院后中位生存21.9个月。校正竞争风险模型显示急性病情严重度与死亡强相关,而实际年龄不相关;ANZROD对ICU死亡(AUROC 0.90)和院内死亡(AUROC 0.82)的判别力优于SOFA和APACHE III。作者认为这些发现支持对极端高龄者ICU收治进行个体化临床决策,而非基于年龄的排除。

要点

  • 460例百岁老人ICU收治中院内死亡率13.7%、ICU死亡率3.9%,死亡多发生在住院早期。
  • 医院存活者中54.1%出院回家,出院后中位生存21.9个月。
  • 校正竞争风险模型显示急性病情严重度与死亡强相关,而实际年龄不相关。
  • ANZROD对ICU死亡(AUROC 0.90)和院内死亡(AUROC 0.82)判别力优于SOFA和APACHE III。
  • 33.9%记录了治疗限制医嘱,仅10.3%使用有创机械通气,收治人群高度选择。

适用人群与场景

  • 2010至2024年澳大利亚和新西兰重症监护学会成人患者数据库中所有年龄≥100岁的首次ICU收治患者,共460例,中位年龄100.9岁(IQR 100.3–102.0),女性67.2%,外科收治占67.2%。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入澳大利亚和新西兰成人患者数据库中2010至2024年所有年龄≥100岁的首次ICU收治,共460例。
  • 主要终点院内死亡率为13.7%,ICU死亡率为3.9%,死亡多发生在住院早期。
  • 33.9%记录了治疗限制医嘱,10.3%使用有创机械通气。
  • 医院存活者中54.1%出院回家,出院后中位生存21.9个月;次要结局包括6个月、1年和2年生存。
  • 校正竞争风险模型显示急性病情严重度与死亡强相关,而实际年龄不相关。
  • ANZROD对ICU死亡的AUROC为0.90、对院内死亡的AUROC为0.82,判别力优于SOFA和APACHE III。

证据类型、等级与局限

  • 证据类型为回顾性队列研究;原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些发现支持对极端高龄者ICU收治进行个体化临床决策,而非基于年龄的排除。
  • 收治百岁老人时,急性病情严重度是死亡相关因素,而实际年龄不相关,可据此与家属沟通预后。
  • 该队列中治疗限制医嘱常见(33.9%)、有创机械通气不常见(10.3%),提示收治人群高度选择。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The centenarian population is increasing globally, yet data describing intensive care unit (ICU) outcomes in this age group remain limited. We aimed to describe the clinical characteristics and outcomes of centenarians admitted to ICU and to evaluate the performance of commonly used severity-of-illness scores for mortality prediction. METHODS: This retrospective cohort study included all index ICU admissions of patients aged ≥100 years recorded in the Australian and New Zealand Intensive Care Society Adult Patient Database between 2010 and 2024. The primary outcome was in-hospital mortality. Secondary outcomes included ICU mortality, discharge destination, and survival at 6 months, 1 year, and 2 years. Competing-risk regression was used to assess factors associated with mortality. Discrimination of SOFA, APACHE III, and ANZROD was evaluated using the area under the receiver operating characteristic curve (AUROC). RESULTS: Among 460 centenarians, the median age was 100.9 years (IQR 100.3–102.0), and 67.2% were female. Surgical admissions predominated (67.2%). Treatment limitation orders were documented in 33.9% of patients, whereas invasive mechanical ventilation was used in 10.3%. In-hospital mortality was 13.7%, and ICU mortality was 3.9%, with most deaths occurring early during hospitalisation. Among hospital survivors, 54.1% were discharged home, with a median post-discharge survival of 21.9 months. Acute illness severity was strongly associated with mortality in adjusted competing-risk models, whereas chronological age was not. ANZROD demonstrated superior discrimination for ICU mortality (AUROC 0.90) and hospital mortality (AUROC 0.82) compared with SOFA and APACHE III. CONCLUSION: In this binational cohort, ICU admission among centenarians was infrequent and occurred in a highly selected population. Treatment limitation orders were common and mechanical ventilation was uncommon; approximately half of hospital survivors were discharged directly home. In-hospital mortality was relatively low and more strongly associated with acute illness severity than with chronological age. These findings support individualised clinical decision-making regarding ICU admission at extreme age rather than age-based exclusion.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Raykateeraroj N, Weinberg L, Yip S, et al. Critical illness at extreme age: outcomes and clinical characteristics of centenarian ICU admissions in Australia and New Zealand. Crit Care. 2026. PMID: 41882770. doi:10.1186/s13054-026-05968-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。